Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
17.93
-0.29 (-1.59%)
At close: Feb 20, 2026, 4:00 PM EST
17.98
+0.05 (0.28%)
After-hours: Feb 20, 2026, 7:34 PM EST
Eton Pharmaceuticals Revenue
Eton Pharmaceuticals had revenue of $22.46M in the quarter ending September 30, 2025, with 117.54% growth. This brings the company's revenue in the last twelve months to $70.32M, up 102.77% year-over-year. In the year 2024, Eton Pharmaceuticals had annual revenue of $39.01M with 23.29% growth.
Revenue (ttm)
$70.32M
Revenue Growth
+102.77%
P/S Ratio
6.84
Revenue / Employee
$2,268,258
Employees
31
Market Cap
480.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.01M | 7.37M | 23.29% |
| Dec 31, 2023 | 31.64M | 10.39M | 48.90% |
| Dec 31, 2022 | 21.25M | -581.00K | -2.66% |
| Dec 31, 2021 | 21.83M | 21.79M | 55,879.49% |
| Dec 31, 2020 | 39.00K | -920.00K | -95.93% |
| Dec 31, 2019 | 959.00K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emergent BioSolutions | 788.90M |
| Organogenesis Holdings | 465.22M |
| Ironwood Pharmaceuticals | 338.99M |
| Esperion Therapeutics | 303.80M |
| Evolus | 285.82M |
| Akebia Therapeutics | 225.07M |
| Canopy Growth | 203.04M |
| Kamada | 174.79M |
ETON News
- 1 day ago - Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th - GlobeNewsWire
- 19 days ago - Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate - GlobeNewsWire
- 4 weeks ago - Eton Pharmaceuticals: An Undervalued Small Cap With High Growth - Seeking Alpha
- 3 months ago - Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th - GlobeNewsWire
- 3 months ago - Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th - GlobeNewsWire
- 3 months ago - Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - GlobeNewsWire